The POINT BIOPHARMA brand, founded in 2018 (United States), from 588 sister brands and 17479 competing brands. POINT BIOPHARMA is a brand of ELI LILLY AND COMPANY, listed on the stock exchange of New York. POINT BIOPHARMA is part of the Drug Manufacturers activity sector.

POINT BIOPHARMA is a brand of ELI LILLY AND COMPANY (LLY) Share price

International deposit : 2018 Business sector Drug Manufacturers

Share price and profitability of the share ELI LILLY AND COMPANY (POINT BIOPHARMA)

Buy ELI LILLY AND COMPANY share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested $804.62

Portfolio valuation
ELI LILLY AND COMPANY (POINT BIOPHARMA) over 5 years* $5,927.74

Stock market history ELI LILLY AND COMPANY (POINT BIOPHARMA)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
ELI LILLY AND COMPANY

DICE MOLECULES
DICE MOLECULES
DICE Therapeutics
DICE Therapeutics
Versanis
Versanis
ChemGen
ChemGen
Pharmaserve-Lilly
Pharmaserve-Lilly
LOXO ONCOLOGY
LOXO ONCOLOGY
See more brands of ELI LILLY AND COMPANY

Rival brands
POINT BIOPHARMA

Fusion Pharmaceuticals
Fusion Pharmaceuticals
Icosavax
Icosavax
OGX
OGX
MAUI MOISTURE
MAUI MOISTURE
POLYSPORIN
POLYSPORIN
LACTAID
LACTAID
OTHER RIVAL BRANDS

Top Popularity Web

BACKTEST ET OUTLOOK PAR INDUSTRY
Desirable brands > Pricing Power > 5 major sectors
Desirable brands > Pricing Power > 5 major sectors

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS